- Hospital Expansion Will Highlight Advanced Intraoperative Imaging
WINNIPEG, March 29, 2012 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
("IMRIS" or the "Company") today announced the purchase of a VISIUS
Surgical TheatreTM by the First Affiliated Hospital of Zhengzhou University in Zhengzhou
City, Henan Province in central China. Zhengzhou University Hospital
is one of the largest hospitals in China, with a neurosurgical
department ranked in the top 15 in the country.
Kan Quancheng, President of Zhengzhou University Hospital said: "We
believe the VISIUS Surgical Theatre is the essential, leading-edge
technology that will take us to the next level of research and clinical
practice, especially in Neurosurgery. We are looking forward to
working with IMRIS to achieve our goals". Considering the research
opportunities, Cheng Jingliang, Chief Radiologist, added: "Not only the
ideal solution for Neurosurgery, "The VISIUS Surgical Theatre will
provide us with the best available technology platform for new research
in the field of intraoperative MR imaging".
The VISIUS Surgical Theatre at Zhengzhou University Hospital features a
high-field (3 Tesla) MR scanner that travels on demand on
ceiling-mounted rails into a state-of-the-art neurosurgical OR for
imaging without ever moving the patient. When not needed for
intraoperative imaging, the scanner remains in the diagnostic room
where it can be used for inpatient and outpatient imaging. With
integrated technologies and control systems for imaging,
patient-handling and information management, the VISIUS Surgical
Theatre will provide unmatched intraoperative vision to the surgeons at
Zhengzhou University Hospital, assist their surgical decision-making
and enhance precision in their treatment of patients.
Ke Ning, Vice President and General Manager for IMRIS China, commented
on the purchase: "It is an honor to be selected by Zhengzhou University
Hospital and to be part of the growth of such an important hospital in
China". David Graves, CEO IMRIS, added: "This is our third project in
China, and it serves as a reflection of our commitment to this market
and our performance as a global provider of image guided therapy
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions through its VISIUS Surgical Theatre - a
revolutionary, multifunctional surgical environment that provides
unmatched intraoperative vision to clinicians to assist in decision
making and enhance precision in treatment. VISIUS Surgical Theatres
serve the neurosurgical, cardiovascular and cerebrovascular markets and
have been selected by leading medical institutions around the world.
SOURCE IMRIS Inc.